Metimedia Bio Pharmaceutical Company Based In South Koreais At The Forefront Of Cutting Edge Research In Immuno Oncologythe Company Is Committed To Developing A Unique Platform Technology That Addresses The Unmet Needs Of Solid Cancer Therapies And Beyondby Targeting Specific Cellular Metabolic Reprogramming In Tumor Cellsmetimedi S Immunotherapy Leads To Tumor Necroptosis And Immune Activationwith Exceptional Safetyphase 2 Clinical Studies With Meti 101 For Refractory Metastatic Colorectal Cancer Have Demonstrated Efficacy And Safety
No conferences found for this company.
| Company Name | Metimedi Pharmaceuticals Co Ltd |
| Country |
South Korea
|
| Address | N/A |
| Telephone | N/A |
| N/A |
